Literature DB >> 1607703

Ketoconazole in the treatment of antimony- and pentamidine-resistant kala-azar.

J P Wali, P Aggarwal, U Gupta, S Saluja, S Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1607703     DOI： 10.1093/infdis/166.1.215

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum.

Authors:  J P Gangneux; M Dullin; A Sulahian; Y J Garin; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 2.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

3.  Visceral leishmaniasis (kala-azar) after a visit to the Mediterranean region.

Authors:  J Rudi; P Racz; M Hörner; B Kommerell
Journal:  Clin Investig       Date:  1993-08

Review 4.  Therapeutic options for visceral leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.